Subscribe to Newsletter

Amir Kashani

The Power List 2017

Amir Kashani

Assistant Professor of Clinical Ophthalmology and Director of the Ocular Imaging Center at USC Roski Eye Institute, ARCADIA, CA, USA

A clinician-scientist developing novel diagnostic and therapeutic methods to treat retinal diseases, Kashani is the principal investigator for a number of ongoing trials of stem cell therapies for the treatment of AMD. He’s also investigating the use of advanced imaging spectroscopy and OCT methods to improve the diagnosis and treatment of retinal diseases, and recently co-authored a book entitled ‘Optical Coherence Tomography and OCT Angiography: Clinical Reference and Case Studies.’

An advocate for continued NIH funding for research into blinding eye diseases, he testified in front of the US Congress in 2016 to highlight International Age-Related Macular Degeneration Awareness Week and to argue for continued NIH funding support. Kashani and his wife recently had their third child – and with three children under five, his aim is to spend time with his family when not in the clinic or the lab.

Part of the Power List 2017

Top 50 rising stars

Thanks to the demographics of the developed world, the future of eyecare looks like it will be one of limited resources and rising patient burden.

So who will lead ophthalmology over the next few decades and shape its future? To find out, we asked you, our readers, to vote for ophthalmology’s Top 50 rising stars… and here they are.

Welcome to the 2017 Power List.

In 2018, The Ophthalmologist will be recognising the Top 100 pioneers and game-changers in the field of ophthalmology.

Go to The Power List 2017

Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine



The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: